BioinformaticsCancersPeer-reviewed
Isolated BAP1 loss in malignant pleural mesothelioma predicts immunogenicity with implications for immunotherapeutic response
Hatice U. Osmanbeyoglu, Drake Palmer, April Sagan…·Joseph R. Testa
The paper identifies BAP1 loss as a predictor of immunogenicity and potential response to PD-1 therapy in malignant pleural mesothelioma.
15 citations